Erectile dysfunction decisions — 2025

The Board granted service connection for esophageal cancer, benign prostate hypertrophy, and erectile dysfunction secondary to the now service-connected benign prostate hypertrophy. The claims for larynx cancer, peripheral neuropathy of the upper and lower extremities, diabetes, an acquired psychiatric disorder, and a stomach disorder were denied.

The Veteran's service connection for asthma was denied, but a total disability rating based on individual unemployability (TDIU) from October 11, 2017 was granted.

The Board remands the service connection claims for bladder cancer, hypertension, anxiety, depression, and erectile dysfunction due to a pre-decisional duty-to-assist error regarding herbicide exposure in Korea.

The Board denied the veteran's claims for increased ratings for gastroesophageal reflux disease, erectile dysfunction, and neurogenic bladder.

The Board remands the claim for service connection of erectile dysfunction/penile condition to obtain additional medical evidence.

The Board granted service connection for prostate cancer and kidney cancer under the PACT Act, but remanded claims for erectile dysfunction, prostate cancer on a basis other than the PACT Act, and kidney cancer on a basis other than the PACT Act.

The Board granted an effective date of January 15, 2021, for service connection for prostate cancer and related conditions.

The Board dismissed the appeals for service connection for various conditions as a matter of law due to claims processing errors preventing concurrent review.

The Board remands the claims for service connection for type II diabetes mellitus, eczema (claimed as a skin disability), and erectile dysfunction to schedule new VA examinations.

The Board denied service connection for erectile dysfunction as there is no evidence of a current diagnosis.

The Board granted earlier effective dates for service connection of right knee strain, lower extremity radiculopathies, and DEA benefits, but denied earlier effective dates for erectile dysfunction and special monthly compensation.

The Board denied the veteran's claims for a higher rating for tension headaches, a compensable rating for erectile dysfunction, and special monthly compensation for loss of use of a creative organ prior to August 12, 2022.

The Board remands the claims for service connection for erectile dysfunction, GERD, Barret's Esophagus, and a hiatal hernia due to inadequate VA examinations and opinions.

The veteran withdrew the appeals for service connection of multiple conditions, including left and right knee disabilities, tension headaches, elbow and wrist disabilities, lumbar spine disability, sciatica of the right leg, and erectile dysfunction.

The Board grants service connection for erectile dysfunction, which is found to be proximately due to the Veteran's service-connected hypertension.

The Board denied service connection for bilateral pes planus and erectile dysfunction as the evidence did not support that these conditions were related to the Veteran's military service.

The Board denied service connection for chronic obstructive pulmonary disease, respiratory condition, and erectile dysfunction as they are not related to the Veteran's in-service exposure to herbicide agents.

The Board granted service connection for diabetes mellitus type II, erectile dysfunction, and diabetic peripheral neuropathy of both lower extremities, effective July 3, 2022.

The Board dismissed the claims for service connection for erectile dysfunction, lumbosacral strain (claimed as back injury), mental health disorder, and right knee condition due to untimely filing of a notice of disagreement.

The Board granted the reopening of the claim for a left hip disability and a 20 percent rating for scars on the left knee, lower left leg, and distal end fibula. The other claims were remanded.